Clinical Trials Browser

Fanconi Anemia, Complementation Group D1, Breast Neoplasms

NCT05485766 2025-03-20

Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer

Phase 2 Recruiting

23 enrolled

BreastClassical hematology

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03889171 2019-03-28

PSICOM

Completed

200 enrolled

BreastClassical hematologyGastrointestinalGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Genetic Predisposition to Disease

NCT02418624 2019-01-16

REVIVAL

Phase 1 Completed

25 enrolled

BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

NCT02959398 2017-11-24

ETOLE

Phase NA Unknown

2,000 enrolled

BreastClassical hematology

Fanconi Anemia, Complementation Group D1, Breast Neoplasms

NCT00419510 2016-08-17

Genetic Counseling in African American Women

Phase NA Completed

204 enrolled

BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

NCT01346761 2016-04-14

REACH

Phase NA Completed

1,012 enrolled

BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms, Genetic Predisposition to Disease

NCT00580021 2016-01-28

Clinical Outcomes in Hereditary Cancer

Withdrawn

BreastClassical hematologyGastrointestinal

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Pancreatic Neoplasms

NCT00776958 2014-07-31

Lynne Cohen Consortium Project: Multi-Center Database/Registry

Completed

176 enrolled

BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Neoplasms, Ovarian Neoplasms

NCT00413491 2014-05-20

MR BRCA

Phase 4 Unknown

300 enrolled

BreastClassical hematology

Fanconi Anemia, Complementation Group D1, Breast Neoplasms

NCT00165152 2012-08-09

Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing

Phase NA Completed

150 enrolled

BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Ovarian Neoplasms

NCT00509509 2012-05-24

High Risk Breast Cancer Screening Program

Unknown

BreastClassical hematology

Breast Cancer, Familial, Fanconi Anemia, Complementation Group D1, Breast Neoplasms

Clinical Trials

Olaparib In Metastatic Breast Cancer

Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer

PSICOM

REVIVAL

ETOLE

Genetic Counseling in African American Women

REACH

Clinical Outcomes in Hereditary Cancer

Lynne Cohen Consortium Project: Multi-Center Database/Registry

MR BRCA

Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing

High Risk Breast Cancer Screening Program